SCHEMBL13901271

SCHEMBL13901271

CCC(CC)C(=O)N1CCC(C)CC1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
NPC1 O15118 1/20 0.50
CYP2C19 P33261 1/20 0.46
PHGDH O43175 1/20 0.44
MGLL Q99685 1/20 0.44
HPGD P15428 2/20 0.43
DPP4 P27487 5/20 0.42
DPP8 Q6V1X1 3/20 0.42
DPP7 Q9UHL4 2/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.41
EPHX2 P34913 2/20 0.41
ACHE P22303 1/20 0.41
POLB P06746 1/20 0.40
DPP9 Q86TI2 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16435174 0.82 ALDH1A1 (0.61) ALDH1A1MEN1KMT2ANPC1PHGDH
SCHEMBL15247299 0.82 CYP2C19 (0.49) ALDH1A1MEN1KMT2ACYP2C19DPP4
SCHEMBL16368739 0.82 ALDH1A1 (0.61) ALDH1A1MEN1KMT2ANPC1PHGDH
SCHEMBL4057803 0.82 GNAI3 (0.47) ALDH1A1MEN1KMT2ACYP2C19DPP4
SCHEMBL13901222 0.82 EPHX2 (0.51) ALDH1A1MEN1KMT2ACYP2C19DPP4
SCHEMBL8342259 0.79 EPHX2 (0.48) ALDH1A1MEN1KMT2ACYP2C19DPP4
SCHEMBL20746935 0.79 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ANPC1HPGD
SCHEMBL13266483 0.79 CYP2C19 (0.51) ALDH1A1MEN1KMT2ACYP2C19HPGD
SCHEMBL17546274 0.78 ALDH1A1 (0.56) ALDH1A1MEN1KMT2ANPC1PHGDH
SCHEMBL22698942 0.78 CYP2C19 (0.42) ALDH1A1MEN1KMT2ACYP2C19DPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7511144-B2 Reverse hydroxamic acid derivatives KAKEN PHARMACEUTICAL CO., LTD. (JP) 2009-03-31 US disclosed
US-7511144-B2 Reverse hydroxamic acid derivatives KAKEN PHARMACEUTICAL CO., LTD. (JP) 2009-03-31 US disclosed
EP-1431285-B1 REVERSE HYDROXAMIC ACID DERIVATIVES KAKEN PHARMA CO LTD (JP) 2009-01-07 EP disclosed